Product
AZD 1775
1 clinical trial
4 indications
Indication
Ovarian CancerIndication
Triple-negative breast cancerIndication
small cell lung cancerIndication
Other Solid TumoursClinical trial
A Phase Ib, Open-Label, Multi-Centre Study to Assess the Safety, Tolerability, Pharmacokinetics, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid TumoursStatus: Completed, Estimated PCD: 2018-01-25